Trial
NCT00543712
A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Genentech, Inc.
Collaborators
—
Condition
Chondrosarcoma
Intervention
PRO95780
Why stopped
Efficacy not evident in this population.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-12-13